← Every company
Madrigal Pharmaceuticals Inc Lobbying
What Madrigal Pharmaceuticals Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
MDGL on carbonthat →Disclosed spend
$1.2M
across every filing on file
Filings
9
Years covered
1
Firms retained
4
What it lobbies about
Medicare/MedicaidHealth IssuesPharmacyMedical/Disease Research/Clinical Labs
9 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | MADRIGAL PHARMACEUTICALS, INC.Medicare/MedicaidHealth Issues | $380K |
| 20261st Quarter (Jan 1 - Mar 31) | MADRIGAL PHARMACEUTICALS, INC.Medicare/MedicaidHealth Issues | $380K |
| 20262nd Quarter (Apr 1 - June 30) | BALLARD PARTNERSPharmacy | $120K |
| 20261st Quarter (Jan 1 - Mar 31) | BALLARD PARTNERSPharmacy | $120K |
| 20262nd Quarter (Apr 1 - June 30) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | CROSSROADS STRATEGIES, LLCMedicare/MedicaidHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on MDGL
Company overviewEverything on MDGL in one place, with the price.SEC filingsWhat MDGL's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat MDGL's own officers and directors buy and sell.Planned salesSales MDGL insiders have filed notice of.Who owns itEvery manager reporting a position in MDGL.Funds holding itWhich funds and ETFs hold MDGL, and how big a bet.Who lobbies for itThe lobbyists on MDGL's account, and who they worked for.Federal contractsWhat federal agencies pay MDGL.PatentsWhat MDGL is filing at the patent office.